Astellas Pharma Inc (ALPMF) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Astellas Pharma Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.142 Thank you very much for joining our FY2024 Financial Results Announcement 00:00:05.142 -- 00:00:09.732 meeting by Astellas Pharma Inc. out of a very busy schedule today. 00:00:09.732 -- 00:00:14.482 I'm delighted to serve as a moderator. I'm Ikeda, Chief Communications and IR Officer. 00:00:14.482 -- 00:00:19.994 Thank you for your time. Today, after presentation, we will move on to Q&A session. 00:00:19.994 -- 00:00:25.001 Presentation will be made based on the material posted on our website under the IR 00:00:25.001 -- 00:00:29.608 meeting section. We have simultaneous translation between Japanese and English, including 00:00:29.608 -- 00:00:33.013 Kyonei. We cannot guarantee the accuracy of the translation. 00:00:33.013 -- 00:00:38.060 Thank you for your understanding. You can choose the language from the menu 00:00:38.060 -- 00:00:40.504 on the Zoom webinar screen. 00:00:40.504 -- 00:00:44.870 If you select the original language, you can listen to the original sound without going 00:00:44.870 -- 00:00:47.251 through the translation. 00:00:47.821 -- 00:00:53.509 Disclaimer for today. This material or presentation by representatives for the company 00:00:53.509 -- 00:00:57.475 and their answers and statement in the Q&A session includes forward-looking statements 00:00:57.475 -- 00:01:02.102 based on assumptions and beliefs in light of information currently available to management 00:01:02.102 -- 00:01:06.168 and subject to significant risks and uncertainties. 00:01:06.168 -- 00:01:11.653 Actual financial results may differ materially depending on a number of factors. 00:01:13.336 -- 00:01:18.444 They contain information on pharmaceuticals, including compounds and development, but 00:01:18.444 -- 00:01:22.872 this information is n...